Hollow‐Fiber Methodology for Pharmacokinetic/Pharmacodynamic Studies of Antimalarial Compounds-Reference-Cited by-同舟云学术

Hollow‐Fiber Methodology for Pharmacokinetic/Pharmacodynamic Studies of Antimalarial Compounds

Published:2016-03 Issue:1 Volume:8 Page:29-58
ISSN:2160-4762
Container-title:Current Protocols in Chemical Biology
language:en
Short-container-title:Current Protocols in Chemical Biology

Author:

Caton Emily¹,Nenortas Elizabeth¹,Bakshi Rahul P.¹,Shapiro Theresa A.¹

Affiliation:

1. Division of Clinical Pharmacology, Departments of Medicine and of Pharmacology and Molecular Sciences, and The Johns Hopkins Malaria Research Institute, The Johns Hopkins University Baltimore Maryland

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/9780470559277.ch150194

Reference25 articles.

1. Antimicrobial Resistance: Pharmacokinetics‐Pharmacodynamics of Antimicrobial Therapy: It’s Not Just for Mice Anymore

2. The global pipeline of new medicines for the control and elimination of malaria

3. Model System to Define Pharmacokinetic Requirements for Antimalarial Drug Efficacy

4. Two compartment kinetic model with multiple artificial capillary units

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New In Vitro Interaction-Parasite Reduction Ratio Assay for Early Derisk in Clinical Development of Antimalarial Combinations;Antimicrobial Agents and Chemotherapy;2022-11-15

2. A microfluidic system that replicates pharmacokinetic (PK) profiles in vitro improves prediction of in vivo efficacy in preclinical models;PLOS Biology;2022-05-26

3. A new in vitro checkerboard-parasite reduction ratio interaction assay for early de-risk of clinical development of antimalarial combinations;2022-04-21

4. Kinetic Driver of Antibacterial Drugs against Plasmodium falciparum and Implications for Clinical Dosing;Antimicrobial Agents and Chemotherapy;2019-11

5. Model System Identifies Kinetic Driver of Hsp90 Inhibitor Activity against African Trypanosomes and Plasmodium falciparum;ANTIMICROB AGENTS CH;2018